We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved elafibranor (Iqirvo) to treat adult patients with a rare type of liver disease known as primary biliary cholangitis (PBC).
As with any medicine, the MHRA will keep the safety and effectiveness of seladelpar under close review.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Find out which types of food are zero-rated and which are standard-rated for VAT purposes.
Evidence and information to help healthcare professionals raise awareness of risk factors for liver disease.
Data update of indicators in the liver disease profiles interactive tool.
Bulletin containing main points from the update of indicators in the liver disease profile.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).